Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001570562-23-000062
Filing Date
2023-05-08
Accepted
2023-05-08 16:02:51
Documents
17
Period of Report
2023-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A eols2022definitiveproxy.htm DEF 14A 606753
2 bradystewartheadshot.jpg GRAPHIC 2890507
3 chart-17314c39def440958df.jpg GRAPHIC 20117
4 chart-768fc59b22cf411088b.jpg GRAPHIC 24912
5 chart-c75b6a0383034e7fbf5.jpg GRAPHIC 24418
6 davidgillheadshot.jpg GRAPHIC 3378461
7 davidmoatazediheadshot.jpg GRAPHIC 3682815
8 dmsignature.jpg GRAPHIC 5036
9 evolus23registered.jpg GRAPHIC 12793
10 evolusinc_vxcvxautoxprxyxp.jpg GRAPHIC 84461
11 evolusinc_vxcvxautoxprxyxpa.jpg GRAPHIC 105060
12 image9.jpg GRAPHIC 8908
13 karahparschauerheadshot.jpg GRAPHIC 2383572
14 petercfarrellphddscheadshot.jpg GRAPHIC 2480901
15 roberthaymanheadshot.jpg GRAPHIC 3131715
16 simoneblankheadshot.jpg GRAPHIC 2814107
17 vikrammalikheadshot.jpg GRAPHIC 3191079
  Complete submission text file 0001570562-23-000062.txt   33945222
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38381 | Film No.: 23897648
SIC: 2834 Pharmaceutical Preparations